daunorubicin has been researched along with Thymoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourgeois, S; Gruol, DJ; Trotter, J; Zee, MC | 1 |
| Hama-Inaba, H; Matsushima, T; Mori, M; Muto, M; Ohyama, H; Saitoh, T; Takusagawa, M; Wang, B; Yamada, T | 1 |
| Mihich, E; Orsini, F; Pavelic, Z | 1 |
| Ujiie, T | 1 |
| McKenzie, IF; Pietersz, GA; Smyth, MJ | 2 |
6 other study(ies) available for daunorubicin and Thymoma
| Article | Year |
|---|---|
Reversal of multidrug resistance by RU 486.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Colchicine; Daunorubicin; Dexamethasone; Drug Resistance; Female; Kinetics; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mifepristone; Phenotype; Puromycin; Structure-Activity Relationship; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Verapamil | 1994 |
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl Methanesulfonate; Mice; Mitomycin; Mutagens; Radiation Tolerance; Sphingosine; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Topics: Animals; Antigens, Neoplasm; Cell Adhesion; Cell Separation; Cells, Cultured; Cytotoxicity Tests, Immunologic; Daunorubicin; Doxorubicin; Epitopes; Immunity, Cellular; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Spleen; Thymoma; Time Factors | 1977 |
Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Cytotoxicity, Immunologic; Daunorubicin; Doxorubicin; Female; Immunity, Innate; Immunization; Mice; Mice, Inbred C57BL; Mitomycin; Mitomycins; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Spleen; Thymoma; Tumor Cells, Cultured | 1988 |
Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates.
Topics: Adrenergic beta-Antagonists; Animals; Antibodies, Monoclonal; Cell Division; Cyclandelate; Daunorubicin; DNA Replication; Idarubicin; Mandelic Acids; Mice; Mice, Inbred Strains; Perfusion; Prazosin; Thymoma; Thymus Neoplasms | 1987 |
Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Division; Cell Line; Cell Survival; Daunorubicin; Humans; Idarubicin; Immunotherapy; Mice; Mice, Inbred Strains; Thymoma; Thymus Neoplasms | 1988 |